Altasciences vs CytoReason
Altasciences vs CytoReason, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Altasciences is on 70/100 and CytoReason on 68/100.
Where each one leads
Altasciences
- agent readiness: 39/100 against 21/100
- domain rating: 49/100 against 40/100
- headcount: 1,896 against 116
- LinkedIn following: 42,982 against 12,830
CytoReason
- funding raised: $128M against $79.0M
At a glance
| Measure | Altasciences | CytoReason |
|---|---|---|
| What it is | Integrated drug development solutions for pharmaceutical and biotechnology companies, from preclinical to clinical trials. | Develops a computational model of the human body for drug discovery and development. |
| Category | Biotech & Longevity, Drug Discovery, Clinical Trials, Contract Research Organization | Healthcare, Drug Discovery, Clinical Development, Biomarkers |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Software |
| Founded | 1992 | 2016 |
| Headquarters | Laval, Canada | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | Altasciences | CytoReason |
|---|---|---|
| Employees | 1,896 | 116 |
| Headcount growthLast 12 months | Not published | +13.7% |
| Open roles | 77 | Not published |
| Total funding | $79.0M | $128M |
| Latest round | Not published | Series B |
| LinkedIn followers | 42,982 | 12,830 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Altasciences | CytoReason |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 70/100 | 68/100 |
| Traction | Not published | 60/100 |
| Team | 72/100 | 70/100 |
| Search visibility | 83/100 | 30/100 |
| Quality | Not published | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 49/100 | 40/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Altasciences | CytoReason |
|---|---|---|
| Hosting | Self Managed | Not detected |
| Analytics | Google Tag Manager, Linkedin Insight | Segment |
Altasciences vs CytoReason: common questions
Which is better, Altasciences or CytoReason?
On our 0-100 score Altasciences rates higher (70/100 against 68/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do Altasciences and CytoReason compare on the numbers?
Altasciences leads on agent readiness (39/100 against 21/100), domain rating (49/100 against 40/100), headcount (1,896 against 116), LinkedIn following (42,982 against 12,830). CytoReason leads on funding raised ($128M against $79.0M).
Read the full Altasciences review and pricing or the CytoReason review and pricing. You can also browse other Altasciences alternatives we track.